Agreed, biotech success is similar to baseball - you hit .300 and you are an allstar. R & R never got it right either, they had high targets for COR too at one point. However, their 30 cent target for COR is better than what they had previously. Only because you can put a 30 cent target on every small cap biotech and you'll be right 80% of the time eventually. (edit) However I still value Dr. Tracy's estimate for COR because its the best estimate that I have access to.
I believe Neuro's pps predictions would easily have been correct had it not been for the artifact problem, and then the FDA ADHD trial rejection.
Just as we have now with the upcoming RD results, people can predict .30 or $1.50, but only one will actually end up happening.
But both predictions are equally accurate right now - it just depends on which way the binary event goes.
I think pps predictions are pretty useful and I appreciate hearing discussions about them - they force logical projections, and provide a basis for estimating the risk/reward in a given stock.
News 
Market Data 
Discover 
